4.5 Review

Lung Cancer in Never Smokers: Delving into Epidemiology, Genomic and Immune Landscape, Prognosis, Treatment, and Screening

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

Hypothesized Explanations for the Observed Lung Cancer Survival Benefit Among Hispanics/Latinos in the United States

Emily Miao et al.

Summary: Hispanic/Latino ethnicity is associated with improved survival from non-small cell lung cancer compared to non-Hispanic Whites, despite potential disparities in access to care and health outcomes. Factors such as intermittent smoking patterns, genetic variation, co-morbidities, and cultural influences likely contribute to this survival advantage, while immigration factors, acculturation, and access to care may have a lesser impact. Further research should explore specific Hispanic/Latino subgroups and different lung cancer subtypes to better understand the underlying mechanisms and extend these benefits to other ethnic and racial groups.

JOURNAL OF RACIAL AND ETHNIC HEALTH DISPARITIES (2023)

Article Oncology

Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC

Sophie M. Ernst et al.

Summary: Next-generation sequencing allows for the reclassification of smoking-associated NSCLC based on individual genomic tumor characteristics, which can help reduce lung cancer stigma.

JOURNAL OF THORACIC ONCOLOGY (2023)

Article Oncology

Cancer statistics, 2023

Rebecca L. Siegel et al.

Summary: The American Cancer Society predicts that there will be 1,958,310 new cancer cases and 609,820 cancer deaths in the United States in 2023. While incidence trends for most cancers are favorable, prostate cancer saw a significant increase of 3% annually from 2014 to 2019. However, the overall cancer death rate continues to decline due to advances in treatment, with a 33% reduction since 1991.

CA-A CANCER JOURNAL FOR CLINICIANS (2023)

Article Cell Biology

TMEM127 suppresses tumor development by promoting RET ubiquitination, positioning, and degradation

Qianjin Guo et al.

Summary: TMEM127 gene mutation leads to pheochromocytomas, and the mutated tumors share precursor cells and transcription regulatory elements with pheochromocytomas carrying RET mutations. In addition, TMEM127 mutation results in the accumulation and increased signaling of RET, and TMEM127 contributes to RET cellular positioning, trafficking, and degradation. This study helps to understand the role of TMEM127 in the development of pheochromocytomas.

CELL REPORTS (2023)

Article Oncology

Heterogeneous Expression of PD-L1, B7x, B7-H3, and HHLA2 in Pulmonary Sarcomatoid Carcinoma and the Related Regulatory Signaling Pathways

Feng Wang et al.

Summary: Pulmonary sarcomatoid carcinoma (PSC) is an aggressive subtype of non-small-cell lung cancer (NSCLC) that doesn't respond well to standard chemotherapy and PD-1/PD-L1 inhibitors. This study found that PD-L1 expression was higher in the epithelial component compared to the sarcomatoid component, and most PSC patients had at least one immune checkpoint expression in both components. Combination immune checkpoint inhibition based on expression profiles may be a personalized and effective treatment strategy.

CANCERS (2023)

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

Article Medicine, General & Internal

Association of Computed Tomographic Screening Promotion With Lung Cancer Overdiagnosis Among Asian Women

Wayne Gao et al.

Summary: As smoking declines, the proportion of lung cancers in nonsmokers will rise, leading to the need for expanded lung cancer screening in lower-risk groups. A study conducted in Taiwan found that LDCT screening was associated with significant lung cancer overdiagnosis in a largely nonsmoking population of Asian women.

JAMA INTERNAL MEDICINE (2022)

Article Oncology

Targeted Next-Generation Sequencing Reveals Exceptionally High Rates of Molecular Driver Mutations in Never-Smokers With Lung Adenocarcinoma

Philip C. Mack et al.

Summary: In lung adenocarcinoma patients, never-smokers tend to have a higher rate of actionable driver mutations. Comprehensive genomic sequencing reveals driver alterations in the majority of never-smokers with lung ADC, with most of them having therapeutic options available. In stage IV patients, never-smokers with EGFR mutant tumors treated with EGFR-directed therapies have significantly improved overall survival compared to smokers.

ONCOLOGIST (2022)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Review Medicine, General & Internal

Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography Modeling Study for the US Preventive Services Task Force

Rafael Meza et al.

Summary: The study modeled the benefits and harms of LDCT screening for lung cancer, finding that starting at age 50 or 55 with a smoking history of 20 pack-years or more had more benefits compared to the 2013 USPSTF recommendations, but also resulted in more false-positive results, overdiagnosed cases, and radiation-related lung cancer deaths.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Article Cell Biology

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer

Yueqin Sun et al.

Summary: The research found that smokers in NSCLC patients receiving ICI treatment had a longer progression-free survival. Further analysis revealed that the smoking group had higher immunogenicity, more gene mutations, and a stronger immune microenvironment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

Article Oncology

PS01.02 National Lung Cancer Screening Program in Taiwan: The TALENT Study

P. Yang

Journal of Thoracic Oncology (2021)

Article Genetics & Heredity

Genomic and evolutionary classification of lung cancer in never smokers

Tongwu Zhang et al.

Summary: Whole-genome sequencing of lung cancer in never smokers identifies different copy number subtypes and shows a lack of tobacco smoking signatures, even in cases exposed to secondhand smoke.

NATURE GENETICS (2021)

Article Oncology

Genomic Profiling of Lung Adenocarcinoma in Never-Smokers

Siddhartha Devarakonda et al.

Summary: The study analyzed genomic and transcriptomic data from never-smoker lung adenocarcinoma samples, finding a high prevalence of clinically actionable driver alterations and potential role of germline variants in DNA repair genes and passive exposure to cigarette smoke in the pathogenesis of a subset of never-smoker LUADs. The findings also highlight the importance of obtaining biopsies with adequate cellularity for clinical genomic testing in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2021)

Article Substance Abuse

Tobacco and Nicotine Use Among US Adult Never Smokers in Wave 4 (2016-2018) of the Population Assessment of Tobacco and Health Study

Elias M. Klemperer et al.

Summary: Many never smokers have tried cigarettes or non-cigarette tobacco/nicotine products, and a significant portion have engaged in regular tobacco use, suggesting that the 100-cigarette lifetime threshold may not accurately represent lack of tobacco exposure. This may lead to underestimates of the harms from cigarettes when using never smokers as reference groups.

NICOTINE & TOBACCO RESEARCH (2021)

Article Oncology

The genomic landscape of nonsmall cell lung carcinoma in never smokers

Bram Boeckx et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Article Multidisciplinary Sciences

Living with parents who smoke predicts levels of toxicant exposure in children

Myung-Bae Park

SCIENTIFIC REPORTS (2020)

Article Oncology

rRole of Low-Dose Computerized Tomography in Lung Cancer Screening among Never-Smokers

Hye-Rin Kang et al.

JOURNAL OF THORACIC ONCOLOGY (2019)

Review Respiratory System

Idiopathic Pulmonary Fibrosis and Lung Cancer A Systematic Review and Meta-analysis

Stacey-Ann Whittaker Brown et al.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2019)

Article Respiratory System

BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers

Sebastien Couraud et al.

EUROPEAN RESPIRATORY JOURNAL (2015)

Review Environmental Sciences

Outdoor Particulate Matter Exposure and Lung Cancer: A Systematic Review and Meta-Analysis

Ghassan B. Hamra et al.

ENVIRONMENTAL HEALTH PERSPECTIVES (2014)

Article Oncology

ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

Kristin Bergethon et al.

JOURNAL OF CLINICAL ONCOLOGY (2012)

Article Oncology

Impact of Reduced Tobacco Smoking on Lung Cancer Mortality in the United States During 1975-2000

Suresh H. Moolgavkar et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)

Article Critical Care Medicine

Long-term Ambient Fine Particulate Matter Air Pollution and Lung Cancer in a Large Cohort of Never-Smokers

Michelle C. Turner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Oncology

Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Harboring BRAF Mutations

Antonio Marchetti et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Oncology

Clinical Characteristics of Patients With Lung Adenocarcinomas Harboring BRAF Mutations

Paul K. Paik et al.

JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Oncology

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer A Brief Report

Tsu-Hui Shiao et al.

JOURNAL OF THORACIC ONCOLOGY (2011)

Editorial Material Cardiac & Cardiovascular Systems

Novel germline mutation: EGFR V843I in patient with multiple lung adenocarcinomas and family members with lung cancer

Koei Ikeda et al.

ANNALS OF THORACIC SURGERY (2008)

Article Oncology

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer

Akiko Tatematsu et al.

CLINICAL CANCER RESEARCH (2008)

Article Oncology

Second hand smoke, age of exposure and tung cancer risk

Kofi Asomaning et al.

LUNG CANCER (2008)

Article Genetics & Heredity

Common 5p15.33 and 6p21.33 variants influence lung cancer risk

Yufei Wang et al.

NATURE GENETICS (2008)

Article Medicine, General & Internal

Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies

Michael J. Thun et al.

PLOS MEDICINE (2008)

Article Oncology

Passive smoking and lung cancer in Japanese non-smoking women: A prospective study

Norie Kurahashi et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Article Oncology

Presentation and stage-specific outcomes of lifelong never-smokers with non-small cell lung cancer (NSCLC)

Janakiraman Subramanian et al.

JOURNAL OF THORACIC ONCOLOGY (2007)

Article Critical Care Medicine

Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers

Michelle C. Turner et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Oncology

Reproductive and hormonal factors and risk of lung cancer in women: A prospective cohort study

Geoffrey C. Kabat et al.

INTERNATIONAL JOURNAL OF CANCER (2007)

Article Oncology

Lung cancer incidence in never smokers

Heather A. Wakelee et al.

JOURNAL OF CLINICAL ONCOLOGY (2007)

Article Oncology

Global cancer statistics, 2002

DM Parkin et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2005)

Article Genetics & Heredity

A major lung cancer susceptibility locus maps to chromosome 6q23-25

JE Bailey-Wilson et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2004)

Article Medicine, General & Internal

Ingested arsenic, cigarette smoking, and lung cancer risk - A follow-up study in arseniasis-endemic areas in Taiwan

CL Chen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Oncology

Hormone replacement therapy and lung cancer risk: A case-control analysis

MB Schabath et al.

CLINICAL CANCER RESEARCH (2004)

Article Radiology, Nuclear Medicine & Medical Imaging

Occupational and environmental thoracic malignancies

EB Gottschall

JOURNAL OF THORACIC IMAGING (2002)

Article Cell Biology

Gender-dependent expression of alpha and beta estrogen receptors in human nontumor and tumor lung tissue

MJ Fasco et al.

MOLECULAR AND CELLULAR ENDOCRINOLOGY (2002)

Article Oncology

Incidence of lung cancer in a large cohort of non-smoking men from Sweden

P Boffetta et al.

INTERNATIONAL JOURNAL OF CANCER (2001)

Article Oncology

Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women

D Feskanich et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)

Article Critical Care Medicine

Lung cancer and cryptogenic fibrosing alveolitis - A population-based cohort study

R Hubbard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)